Urology Times October 23, 2023
“As private equity firms increasingly engage in urology, key stakeholders, including policymakers and urologists, need to ensure that the quality of care is not compromised with the structural changes implemented after acquisition,” write the authors.
Urologists in practices that have been acquired by private equity firms demonstrated lower scores on Medicare’s Merit-based Incentive Payment System (MIPS) compared with those not in acquired practices, according to data published in Urology Practice.1
“At a time when a growing number of medical practices are being acquired by private equity investors, it is essential to take steps to ensure that the quality of care is maintained,” commented lead author Kassem S. Faraj, MD, in a news release on the findings.2 Faraj is a urologic...